The Aptamers Market is witnessing robust growth as these synthetic oligonucleotides continue to revolutionize diagnostics, therapeutics, and targeted drug delivery. Aptamers, often described as “chemical antibodies,” bind to specific molecules with high affinity and selectivity. They are widely used in cancer research, rare disease treatment, biosensing, and drug...